MoneyWorks4Me

The company witnessed a 6.74% growth in the revenue at Rs. 3523.10 millions for the quarter ended June 2023 as compared to Rs. 3300.70 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -198.80 millions as compared to Net Loss of Rs. -191.80 millions of corresponding quarter ended June 2022Operating profit surged to 212.10 millions from the corresponding previous quarter of 161.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3523.10 3300.70 6.74 3523.10 3300.70 6.74 14438.10 12683.40 13.83
Other Income 20.70 64.80 -68.06 20.70 64.80 -68.06 221.40 187.60 18.02
PBIDT 212.10 161.60 31.25 212.10 161.60 31.25 1561.80 991.10 57.58
Interest 255.10 225.00 13.38 255.10 225.00 13.38 900.60 752.70 19.65
PBDT -43.00 -63.40 -32.18 -43.00 -63.40 -32.18 661.20 203.50 224.91
Depreciation 258.30 280.50 -7.91 258.30 280.50 -7.91 1109.00 1120.10 -0.99
PBT -301.30 -343.90 -12.39 -301.30 -343.90 -12.39 -447.80 -916.60 -51.15
TAX -102.50 -152.10 -32.61 -102.50 -152.10 -32.61 -225.70 -331.00 -31.81
Deferred Tax -102.50 -152.10 -32.61 -102.50 -152.10 -32.61 -224.60 -331.00 -32.15
PAT -198.80 -191.80 3.65 -198.80 -191.80 3.65 -222.10 -585.60 -62.07
Equity 360.00 360.00 0.00 360.00 360.00 0.00 360.00 360.00 0.00
PBIDTM(%) 6.02 4.90 22.97 6.02 4.90 22.97 10.82 7.81 38.43
Peers
Company Name CMP
Sun Pharma. Inds. 1849.00
Dr. Reddys Labs. 1198.85
Cipla 1403.85
Lupin 2085.90
Zydus Lifesciences 1196.00
View more..